AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2021
Nov 10, 2021
34491_dirs_2021-11-10_8bf9801f-d989-4a34-88ac-a60bdb68be92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-11-08
Reporting Person: Pire Shari Lisa (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-08 | Stock Option (Right to Buy) | $9.66 | A | 55360 | Acquired | 2031-11-07 | Common Stock (55360) | Direct |
Footnotes
F1: The option vests in 36 substantially equal monthly installments following November 8, 2021, such that the option shall be fully vested on November 8, 2024.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19